Every year on 20 May, the global clinical research community observes International Clinical Trials Day, a moment to recognize the scientific progress, collaboration, and patient participation that make medical advancement…
Lambda conducts early phase BA/BE studies for transdermal and topical products with a focus on pharmacokinetics, adhesion performance, and skin safety. Experience spans multiple molecules and dosage forms, supported by controlled application techniques and consistent study execution.
NEWS
The regulatory environment in 2025 was defined by consolidation, clarification, and higher expectations for execution. Across major regions, regulators focused on improving trial quality, reducing avoidable administrative burden, and enabling scientific progress while maintaining patient safety and data integrity.
On World Cancer Day, we recognize the importance of cancer research in expanding early access to investigational therapies and generating evidence that informs progress in oncology care. At Lambda Therapeutic…
The regulatory environment in 2025 was defined by consolidation, clarification, and higher expectations for execution. Across major regions, regulators focused on improving trial quality, reducing avoidable administrative burden, and enabling scientific progress while maintaining patient safety and data integrity.
Lambda Therapeutic Research provides QPPV services across the EU and UK, offering companies a reliable framework to meet regulatory expectations and maintain inspection readiness at all times.
blog
blog
Lambda Therapeutic Research provides QPPV services across the EU and UK, offering companies a reliable framework to meet regulatory expectations and maintain inspection readiness at all times.
